tiprankstipranks
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF

Compare Newron Pharmaceuticals SpA (NWPHF) vs. Competitors

11 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Newron Pharmaceuticals SpA
$20.00
$392.77M
-9.69
113.68%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF134.85M
-2.50
4.05%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF649.42M
16.63
30.32%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.41
CHF885.27M
-8.17
262.69%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF16.64
CHF236.25M
-0.98
26.44%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF21.50
CHF124.00M
3.99
8.04%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NWPHF
Newron Pharmaceuticals SpA
20.00
10.64
113.68%
CH:MOLN
Molecular Partners AG
3.34
0.30
9.87%
CH:BSLN
Basilea Pharmaceutica
53.30
13.40
33.58%
CH:IDIA
Idorsia Ltd
3.50
2.49
246.53%
CH:SANN
Santhera Pharmaceuticals Holding
16.64
3.94
31.02%
CH:XLS
Xlife Sciences Ltd.
21.50
1.90
9.69%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts